Targeted pharmacokinetics and bioinformatics screening strategy reveals JAK2 as the main target for Xin-Ji-Er-Kang in treatment of MIR injury.
Zhou K, Chen H, Wang XY, Xu YM, Liao YF, Qin YY, Ge XW, Zhang TT, Fang ZL, Fu BB, Xiao QZ, Zhu FQ, Chen SR, Liu XS, Luo QC, Gao S.
Zhou K, et al. Among authors: fang zl.
Biomed Pharmacother. 2022 Nov;155:113792. doi: 10.1016/j.biopha.2022.113792. Epub 2022 Oct 7.
Biomed Pharmacother. 2022.
PMID: 36271569
Free article.